Financhill
Sell
44

RPRX Quote, Financials, Valuation and Earnings

Last price:
$39.26
Seasonality move :
3.43%
Day range:
$39.24 - $39.50
52-week range:
$25.02 - $41.24
Dividend yield:
2.24%
P/E ratio:
22.45x
P/S ratio:
9.56x
P/B ratio:
2.61x
Volume:
1.1M
Avg. volume:
4.3M
1-year change:
55.57%
Market cap:
$16.8B
Revenue:
$2.3B
EPS (TTM):
$1.75

Earnings Data

Next earnings date for RPRX
Feb 10
2026
Most recent earnings per share
$0.67
Missed by $0.38
(Nov 5/2025)
Consensus Estimate
$1.04
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RPRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/10/2026 Q4 $840M -- -- $1.31 --
11/05/2025 Q3 $763.5M $609.3M $0.67 $1.04 -$0.38
08/06/2025 Q2 $693.7M $578.7M $0.07 $1.03 -$0.96
05/08/2025 Q1 $750.5M $568.2M $0.55 $0.95 -$0.41
02/11/2025 Q4 $728M $594M $0.47 $1.05 -$0.59
11/06/2024 Q3 $730.2M $564.7M $1.21 $0.93 $0.29
08/08/2024 Q2 $639.7M $537.3M $0.23 $0.97 -$0.74
05/09/2024 Q1 $700.8M $568M $0.01 $0.98 -$0.97
02/15/2024 Q4 $674.5M $596M $1.11 $1.00 $0.10
11/08/2023 Q3 -- $536.3M $0.16 -- --
08/08/2023 Q2 -- $538.2M $0.50 -- --
05/09/2023 Q1 -- $684M $0.76 -- --
02/15/2023 Q4 -- $566M -$1.03 -- --
11/08/2022 Q3 -- $573.5M $0.32 -- --
08/04/2022 Q2 -- $536M $0.70 -- --
05/05/2022 Q1 -- $562M $0.12 -- --
02/15/2022 Q4 -- $576M $0.02 -- --
11/10/2021 Q3 -- $585.8M $0.24 -- --
08/11/2021 Q2 -- $555M $1.08 -- --
05/11/2021 Q1 -- $573M $0.18 -- --
02/17/2021 Q4 -- $572M $0.44 -- --
11/11/2020 Q3 -- $538.4M $0.79 -- --
08/12/2020 Q2 -- $510.9M $1.21 -- --
03/31/2020 Q1 -- $500.9M $0.19 -- --
12/31/2019 Q4 -- $457.5M $3.88 -- --
09/30/2019 Q3 -- $464.3M $1.12 -- --
06/30/2019 Q2 -- $457.6M $0.41 -- --
03/31/2019 Q1 -- $434.9M $1.00 -- --
03/20/2017 Q4 -- -- -- -- --
11/14/2016 Q3 -- -- -- -- --
08/08/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
03/21/2016 Q4 -- -- -- -- --

Royalty Pharma Plc Earnings Questions

  • How Much did Royalty Pharma Plc Generate in Revenue Last Quarter?

    Royalty Pharma Plc reported $609.3M worth of top line sales in its most recent quarter.

  • Did Royalty Pharma Plc Beat Earnings Last Quarter?

    Royalty Pharma Plc announced earnings per share of $0.67 which represents a miss of analyst forecast a $1.04 per share.

  • Is Royalty Pharma Plc Profitable?

    Royalty Pharma Plc reported $608M that represents $1.09 per share over the last quarter.

  • What is the Analyst Consensus for Royalty Pharma Plc EPS Next Year?

    Royalty Pharma Plc's earnings are forecast to grow from $1.91 per share to $4.05 per share next year representing an increase of 142.54%.

  • When is Royalty Pharma Plc's Earnings Date?

    Royalty Pharma Plc's next earnings date is February 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock